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LITHIUM KNOWLEDGE AMONG PATIENTS WITH BIPOLAR 
DISORDER- A STRUCTURED ASSESSMENT 
Abstract 
Introduction: Bipolar disorder (BD) is a chronic and recurrent illness. 
Lithium is the main treatment for bipolar disorder prophylaxis. Median 
prevalence of lithium non-adherence is 44.7%. Incidence Lithium toxicity is 
5.4 cases /100,000 per year .Higher the knowledge level, the higher the 
adherence and the lower the toxicity risks. Lithium Knowledge Test (LKT) 
identifies patients' practical and pharmacologic knowledge. Hence, we 
decided to use validated Lithium Knowledge Test (LKT)-Tamil version on 
bipolar disorder patients who were on lithium and their relatives, to estimate 
their knowledge about Lithium therapy  
 
Aim: To assess the Knowledge about Lithium therapy among Bipolar 
Disorder patients and their care givers. 
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Methodology: Patients and care givers were assessed for knowledge about 
lithium using validated Lithium knowledge questionnaire (Tamil version) 
and scores were obtained.  
 
Result: Out of 39 patients, 36 participants were getting treatment for manic 
episode and 3 participants were getting treatment for depressive episode. 
The mean LKT scores of patient and relatives were 9.52 (SD=4.32) and 8.53 
(SD=4.65) respectively. Negative Pearson’s correlation was found between 
lithium knowledge score and age of the patient (p=0.033).  Positive 
spearman’s rho correlation was found between patient’s knowledge and 
number of years of education (p=0.005). Negative spearman’s rho 
correlation was found between patient’s knowledge and age of onset of 
illness (p=0.039).Positive correlation was found between patient’s lithium 
knowledge and number of episodes of illness (p=0.026).Positive correlation 
was also found between patient’s knowledge and their care givers 
knowledge (p=0.013).  Others factors like socioeconomic status, duration of 
illness, duration of lithium treatment and number of hospitalization had no 
influence on knowledge.  
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Conclusion: Knowledge about lithium therapy was inadequate among 
patients and care givers. Age of patient, number of years of education, age of 
onset of illness and number of episodes had correlation with patient’s 
lithium knowledge. Good knowledge about lithium in care givers tends to 
influence knowledge of their patients. 
 
Keywords: Lithium, Bipolar Affective disorder, Lithium Knowledge Test, 
Compliance, Relapse, Adherence  
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INTRODUCTION 
Lithium is the first-line maintenance treatment of bipolar affective 
disorder according to recent NICE guidelines, 2014
1
. Lithium acts as a mood 
stabilizer and prevents recurrence of manic episodes and to lesser extent 
depressive episodes. Lithium is being used for more than fifty years in the 
treatment of Bipolar affective disorder. It also helps to prevent suicide in 
patients with mood disorders. It is also used to treat depressive episodes in 
bipolar disorder and as an augmenting agent to antidepressants for unipolar 
depression
2
.It is used as high-dose monotherapy for euphoric mania. Lithium 
is equally efficacious in bipolar disorder compared to valproate for manic, 
depressive, or mixed episodes
3
.  
 
Mechanism of action  
The mechanism of action of Lithium is not clearly understood. It acts 
at various signal transduction sites beyond neurotransmitter receptors 
(Figure1). This includes second messengers, such as the phosphatidyl 
inositol system, where lithium inhibits the enzyme inositol 
monophosphatase; modulates G proteins; and  regulates gene expression for 
growth factors and neuronal plasticity by interaction with downstream signal 
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transduction cascades, including inhibition of GSK-3 (glycogen synthase 
kinase 3) and protein kinase C
 3
 . Other Literature shows that Lithium is an 
element which is similar to sodium in the body. Sodium is present 
everywhere in the human body and is involved in many biological processes. 
There is some evidence that people with bipolar illness have higher 
intracellular concentrations of sodium and calcium when compared with the 
controls. Lithium is said to reduce these levels 
4
.  
 
 
Figure 1: Mechanism of action of Lithium 
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Lithium enhances cognition 
Another potential use of lithium is in cognition; inhibition of GSK-3 
by lithium inhibits the phosphorylation of tau (τ) proteins and thus slows the 
formation of plaques and tangles in Alzheimer’s disease. Few studies have 
shown that lithium can prevent progression from mild cognitive impairment 
to Alzheimer’s disease. It also reduces phosphorylated τ levels, especially 
when it is given for a long duration (> 1 year), even at low doses
3
. Lithium 
has protective cognitive effects also through its effects on 
N‐methyl‐D‐aspartate (NMDA) pathways4. It also has its effects 
on neuroprotective proteins like Bcl-2 and its actions on regulators of 
apoptosis and cellular resilience, such as GSK-3.
5
 
 
Lithium and suicide  
About 15% of people with bipolar affective disorder commit suicide
 6
. 
Studies have shown that Lithium has reduced suicidal rate by 80 % in 
patients with bipolar illness
7
.The mechanism of this protective effect of 
Lithium from suicide is unknown. 
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Adverse Effects 
More than 80% of patient who are on treatment with Lithium 
experience side effects. Regular monitoring of Lithium blood levels 
becomes very important to minimize these adverse effects. The most 
common adverse effects of lithium include gastrointestinal symptoms such 
as dyspepsia, nausea, vomiting, and diarrhea. Other adverse effects are 
weight gain, hair loss, acne, tremor, sedation, decreased cognition, and 
incoordination. There are also long-term adverse effects on thyroid and 
kidney function.
8 
 Lithium is also known to cause interaction with other drugs which are 
commonly used for other medical ailments, which results in either 
augmentation or minimization of the therapeutic action of Lithium thereby 
causing side effects. 
 
Lithium toxicity:  
Lithium has a narrow therapeutic window, so regular monitoring of 
plasma drug levels is required
3
. The therapeutic levelof Lithium ranges from 
0.8-1.2 mmol/L
8
. Lithium toxicity occurs at levels >1.5 mmol/L. The 
symptoms of Lithium toxicity are gastro‐intestinal effects (anorexia, nausea 
and diarrhoea) and CNS effects (muscle weakness, drowsiness, ataxia, 
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course tremor and muscle twitching). At levels above 2 mmol/L, seizures 
and disorientation may occur, sometimes can progress to coma and death. A 
study has shown mortality rate of 9% and permanent neurological damage in 
10% of patients secondary to Lithium intoxication
9
. In the presence of more 
severe symptoms, osmotic or forced alkaline diuresis should be used but not 
thiazide or loop diuretics as it can cause drug interaction with Lithium 
3
. 
Education about toxicity symptoms and risk factors of toxicity should be 
given to patients who are taking Lithium. 
10
 
 
Drug Adherence 
A marked difference has been noted between the efficacy of lithium in 
clinical trials and its effectiveness in day to day clinical practice. This 
difference is mainly attributed to poor treatment adherence
13
. Rates of 
lithium non-adherence are high, ranging from 18% to 52%, with a median 
prevalence of 44.7% 
11
. Another study had shown non-adherence rate of 
medication in unipolar and bipolar disorders ranging from 10 to 60% 
(median 40%)
12
.Even after the introduction of new drugs the prevalence of 
non-adherence is still remains the same. This shows that the attitudes and 
beliefs of patient and family members are more important factors 
contributing to adherence. There are very limited number of studies which 
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assesses the factors contributing to non-adherence and methods to overcome 
it.Non-adherence is associated with multiple risks like increase in relapse 
rate, rehospitalization and lengthier hospital stays. 
A well done study showed that lithium knowledge was the main 
difference between adherent and non-adherent bipolar patients. Studies have 
shown that higher the knowledge level, the higher the adherence and the 
lower the toxicity risks 
13, 14
. So knowledge about the illness and lithium 
therapy is important and it can influence the course of bipolar disorder and 
reduce the risk of toxicity
13
.Several studies have shown that 
psychoeducation interventions are associated with high adherence rates, 
stabilization of plasma lithium levels, reduction of the total number of 
episodes and total number of patients needing to hospitalization.
15, 16
It also 
helps in early detection of prodromal signs followed by prompt drug 
intervention. Compliance also improves with psychoeducation. Education 
about lithium is important in the elderly. Refresher courses are advisable for 
those who have been on lithium for long term management. Interventions 
which modify attitudes and enhance the knowledge are likely to be helpful 
in promoting adherence. 
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Lithium Knowledge test Questionnaire: 
Lithium Knowledge can be systematically assessed using scales like 
Lithium Attitudes Questionnaire (LAQ) and Lithium Knowledge Test 
(LKT)
13,17
. Lithium Knowledge Test (LKT) is a structured, validated scale 
that was developed to identify patients' practical and pharmacologic 
knowledge. One point is scored for each correct answer and one point is 
deducted for each wrong answer. Finally total Lithium Knowledge Score is 
calculated. Some items in questionnaire cover areas of potential hazards to 
patients on lithium. Scores of these items are added up separately to give a 
Lithium Hazard Score (LHS). The original English version has been 
validated in psychiatric population and has shown good reliability  
Another study (reference)used Lithium Knowledge test questionnaire 
as a tool to assess Knowledge about Lithium. Thirty participants, who were 
attending lithium clinic, were giving written handouts and videotape lecture 
about Lithium. A parallel group with thirty patients served as a control 
group. This control group did not receive any health education programme. 
The group which received health education had significant increase in the 
Lithium Knowledge which was measured using Lithium Knowledge Test 
questionnaire. Even the patient’s attitude about Lithium improved after 
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educational programme which was measured using Lithium Attitudes 
Questionnaire. 
 We believe it is imperative that clinicians should estimate the 
knowledge of lithium among patients who are getting lithium therapy so that 
appropriate psychoeducation can be delivered. In our literature search, we 
did not find any published literature from India in this area. Hence, we 
decided to use validated Lithium Knowledge Test(LKT) questionnaire in our 
native language on patients with bipolar disorder who were on lithium, to 
estimate knowledge about Lithium therapy. As all our patients are being 
cared by their family, hence we had planned to estimate the knowledge of 
lithium therapy among primary care givers using the same scale. 
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RATIONALE OF OUR STUDY 
 
There are studies done to assess Lithium knowledge in patients who 
have been taking Lithium, either newly initiated or have been on long term 
maintenance. Few studies have focused on elderly age group people as they 
are more vulnerable to the adverse effects of drug. These studies have used 
structured scales to measure Lithium knowledge. 
 
- To our knowledge there are no studies done in India to 
assess the knowledge about Lithium in patients who are 
taking it for their bipolar illness. 
 
- Similarly there are no studies done which assesses the 
lithium knowledge among primary care givers of patients 
who are on Lithium therapy 
 
- We used Lithium Knowledge Test questionnaire which is 
adapted and validated in native language (Tamil) so that 
knowledge about Lithium can be assessed better. 
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So we planned to do this study to assess the knowledge about Lithium 
among Bipolar disorder patients and their primary care givers using Lithium 
Knowledge Test questionnaire in Tamil language. 
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    REVIEW OF LITERATURE 
Studies show that lifetime prevalence of Bipolar Affective disorder is 
1%. But the prevalence increases to 8% when the concept of bipolar 
affective disorder is extended to include mania, hypomania, brief 
Hypomania and cyclothymia.
18
Several studies have shown that Lithium is 
the main treatment in prophylaxis of bipolar disorder and reduces the 
recurrence of another manic or depressive episode.
19
 
This effectiveness is not seen in regular clinical practice when 
compared with monitored clinical trials. This may be because of poor 
compliance of the patient
14
. There are many reasons for the non-adherence to 
treatment. One of the studies analyzed the reason for non-compliance in long 
term Lithium management in38 bipolar, 21 unipolar and 17 schizoaffective 
patients which was diagnosed according to DSM-III-R. In their study 53.9% 
discontinued prophylaxis treatment during the follow up. In that about 
43.2% of the discontinuations were within first 6 months. The main reason 
for non-adherence of drug in this study was resistance against long-term 
treatment. The non-adherent patients also showed significantly less 
acceptance to the prophylaxis than adherent patients. Even in multivariate 
analysis of various parameters, negative attitude to prophylaxis correlated 
significantly with non-adherence.
20
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Another study which was done to assess the Predictors of non-
adherence in Bipolar affective disorder patients showed treatment non-
adherent individuals had more negative attitudes towards medications,  
fewer reasons for adherence, reduced insight into illness, and more 
perceived reasons for non-adherence when compared with treatment 
adherent individuals. One of the important predictors for non-adherence in 
this study was difficulty with medication routines which had an odds ratio of 
2.2 and another predictor was negative attitudes towards drugs in general 
with an odds ratio of 2.3. In this study even participants with co-morbid 
substance abuse had poor adherence.
21
 
 A study was done in thirty out-patient attending Lithium clinic for 
assessment of precursors of Lithium compliance. The Lithium knowledge 
and attitude was measured using Lithium knowledge test and Lithium 
attitude questionnaire respectively. Mean average score in Lithium 
knowledge test was attained by 52.6% of the participants. Mean average 
score in Lithium attitude questionnaire was achieved by 13.1%. Surprisingly 
in this study Lithium Knowledge, attitude and patients satisfaction did not 
have correlation with the lithium compliance. There was also negative 
correlation between age of patient and Lithium Knowledge, with a 
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significant p value < 0.01. The attitude of Lithium had a decreasing trend 
with increase in number of year on lithium (P<0.05).
22
 
One study was conducted with fourteen studies involving 257 patients 
with a diagnosis of bipolar I disorder
23
.This study analyzed patients who 
stopped taking Lithium. Relapse of new affective episode occurred in more 
than 50% of the study population within 10 weeks of stopping the 
medication. Mania occurred 5.2 times earlier when compared with 
depressive disorder. This study clearly showed that discontinuation of 
Lithium may result in high relapse rate. Another study also showed similar 
results which was conducted to assess why patient on lithium discontinue 
medication. This study shows a relapse rate of 20-75% after discontinuing 
lithium prophylaxis. 
24 
 
A study which was done to assess the factors related to non-
compliance of drugs in patients taking psychotropic medications showed an 
array of cause for non-compliance. This study was done in Indian population 
with 100 participants visiting out-patient clinic. About 56% had transport 
problems, 62% were related to disease characteristics, 52% due to drug side 
effects, 49% cultural myth, 55% due to poor mental health service, 48% due 
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to other social factors, 43% due to economic factors, 36% due to illiteracy 
and 31 % due to poor Knowledge and insight into illness.
25
 
 Dharmendra MS et al. (2003) studied various factors associated with 
knowledge about Lithium treatment in 742 patients. This study showed that 
patients who had positive attitude towards lithium had higher serum lithium 
levels (p =0.005). These patients also had good compliance with a 
significant p value of <0.001. This study concluded that participants with 
high knowledge about Lithium had better adherence rate when compared 
with participants with poor knowledge. Another study which assessed the 
correlation of lithium treatment adherence and treatment attitudes with 
knowledge among bipolar affective disorder patients showed a positive 
correlation between Lithium Knowledge Test with plasma and red blood cell 
lithium. This study concluded that Lithium knowledge level directly 
correlates with treatment adherence and inversely correlates with patients' 
attitudes like opposition to prophylaxis, lower adherence, denial of 
therapeutic effectiveness, fear of side effects and illness severity
13
.  
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Ali Sharifi et al., (2009) have also highlighted that as attitudes and 
beliefs are as important as side-effects of Lithium in predicting adherence 
rate in patients on Lithium.
26 
Adherence to medications is very important as it reduces the relapse 
rate and improves the quality of life. A 6-year naturalistic follow-up study 
which assessed non-adherence with long-term prophylaxis showed only the 
adherent patients having a significant reduction in the number and duration 
of admissions.
20
 
 The major concern while prescribing Lithium is its risk of toxicity. In 
a study which studied incidence, course and changes in renal function of 
Lithium intoxication  by examining a cohort of patients on lithium from 
1997 to 2013 showed that out of 1340 patients, 96 patients had at least one 
episode were their lithium levels was 1.5 mmol/L. The incidence of Lithium 
intoxication was 0.01 per patient-year
27
. Another study done by Oruch, et al. 
(2014) suggests that lithium poisoning frequently occurs, since it is used by 
individuals at high risk of taking an overdose. 
28 
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A study which reviewed Lithium toxicity in 130 cases followed over 5 
years with biochemical lithium toxicity had incidence rate of 5.4 cases per 
100,000 per year. In this study mean toxic level of lithium was 2.16 mmol/L. 
These patients presented mainly with neurological symptoms like tremor, 
ataxia, confusion and drowsiness. In their sample, 50% of patients were on 
medications that interact with lithium and 15% cases were on polypharmacy. 
Subsequently 70% were admitted in hospital and 11% required 
haemodialysis.
29
 
 A study done by Enudi et al., (2014) showed Lithium toxicity had a 
mortality rate of 25% in an acute overdose. In maintenance therapy the 
mortality rate was 9% and 10% of them suffered from permanent neurologic 
damage
2
. Another study showed, out of 23 patients reported two died and 
two developed persisting neurological sequelae.
9
 
 Lithium neurotoxicity is common among the elderly at concentrations 
which are considered to be “therapeutic” in adult populations. This may be 
due to decrease in total body water as the age increases. Therefore, adult 
dosage of lithium in older individuals can result in higher lithium 
concentration and toxicity. Another factor is decrease in glomerular filtration 
rate as age advances. Lithium is a drug which is excreted by the kidney, so 
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in older age group individuals the elimination of lithium through kidneys 
may not be as effective as other general adult population which increases the 
risk of lithium toxicity in the elderly. Other factors include drug interaction 
with various others drugs with are commonly used for medical ailments in 
elderly. Also co-morbid medical illness results in electrolyte imbalance and 
decreased circulating volume
30
. The most common offending drugs which 
cause interaction with lithium are angiotensin-converting enzyme inhibitors, 
thiazide diuretics, and non steroidal anti-inflammatory drugs, which are 
commonly used in the elderly.
31
Also there are studies which have shown 
elderly age group people having less knowledge about Lithium when 
compared with younger people (P<0.001). 
14
 
A study done by Oruch R, et al., (2014) analyzed etiology of Lithium 
intoxication. This study showed 9.9% of the cases of intoxication were due 
to infection, 12.1% cases were associated with starting of drugs which has 
risk of drug interaction with Lithium. Four (4.4%) of these episodes were 
associated with initiation of non-steroidal anti-inflammatory drugs 
(NSAID).Three (3.3%) episodes were associated with initiation of Thiazide 
and loop-diuretics. Seven (7.7%) episodes were accounted by ACE 
inhibitors, angiotensin receptor blockers or spironolactone.
28
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 A study assessed correlation between psychoeducation and serum 
Lithium level
15
. This study showed Mean serum lithium levels were 
significantly higher and more stable in group who received psychoeducation 
when compared with group who did not receive any psychoeducation. 
 May studies have assessed Lithium Knowledge using validated 
questionnaire. A study done by Harvey and Peet (1991) showed that 
Lithium Knowledge can be assessed in patient taking Lithium using 
validated questionnaires like Lithium Knowledge Test (LKT)and Lithium 
Attitudes Questionnaire (LAQ)
 17
. This study compared that Knowledge of 
Lithium among patients with concentration of lithium in red blood cells 
(RBC) as a method of measuring compliance. This study showed that 
increase in lithium knowledge was found to be associated with better 
compliance, which had a significant p value (P<0.05). It was also negatively 
correlated with serum lithium levels (P< 0.02).  One another study done by 
Adriane R Rosa, et al., (2006), also used Lithium Knowledge Test 
questionnaire to assess the Knowledge about Lithium
13
. Another study 
which was done to assess lithium Knowledge among elderly population also 
used Lithium Knowledge Test questionnaire
2
. These studies show that this 
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questionnaire is widely used in all age group population for assessment of 
Lithium Knowledge.   
 This Questionnaire has been adapted and validated in Tamil, which is 
the native language of our study population. This questionnaire is easy to 
understand as it is in simple language. It also has good sensitivity and 
specificity
33
.  
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     AIM 
 To assess the knowledge about Lithium therapy among patients with 
Bipolar Disorder and their care givers. 
 
OBJECTIVES 
Primary Objective: 
Using Lithium Knowledge test questionnaire, to assess knowledge 
about Lithium Therapy in Bipolar Disorder patients and their care givers. 
 
Secondary objective:  
To assess whether the following factors would influence knowledge of 
lithium 
- Sociodemographic variables:  Age, Gender, Education, Marital status, 
substance abuse, occupation, socioeconomic status 
-  Clinical variables: Age of onset, duration of illness, duration on 
lithium treatment, number of episodes and number of hospitalization. 
- Compare patient’s knowledge with their care givers knowledge 
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METHODOLOGY 
Study design: 
This is a cross sectional and descriptive study. 
Sample recruitment: 
Patients admitted in the department of psychiatry with the diagnosis of 
Bipolar Affective Disorder (BPAD) meeting DSM IV TR criteria and who 
were initiated on Lithium therapy are our participants. 
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Inclusion criteria 
All patients >18 years of age with a clinical diagnosis of bipolar 
disorder who received in-patient treatment with lithium during the period 
between May 2015 to August 2016 were screened. Patients, who qualify for 
DSM IV TR criteria of bipolar disorder when interviewed by SCID, were 
recruited for our study. 
 
Exclusion criteria 
1. Patients who have co-morbid substance dependence syndrome other 
than tobacco use are excluded.  
2. Patients who are on other mood stabilizers (sodium valproate, 
carbamazepine, lamotrigine)  
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Materials used in the study: 
I. Patient proforma 
II. Hamilton Depression Rating Scale (HDRS) 
III. Young Mania Rating Scale (YMRS)  
IV. Lithium Knowledge Test Questionnaire (Tamil version) 
 
I. Patient proforma: 
 In this proforma we collected the following details, 
a) Socio-demographic profile of the patient. 
b) Details of substance use. 
c) Diagnosis 
d) Clinical details- Age of onset of illness, No. of episodes, No. of 
Hospitalizations, duration of illness, duration on Lithium, Lithium 
dosage, Serum Lithium level. 
e) Primary care giver and their educational qualification. 
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II. Hamilton Depression Rating Scale (HDRS) 
The HDRS (also known as the Ham-D) is a clinician rating 
scale. It takes 20–30 minutes for its administration. It’s mainly 
devised to assess severity, and change in depressive symptoms in 
adult population. The original version contains 17 items (HDRS17) 
pertaining to depressive symptoms experienced in the past week. A 
21-item version (HDRS21) included extra 4 items, which is intended 
to subtype the depression. A limitation of this scale is, it does not 
assess atypical symptoms of depression (e.g., hypersomnia, 
hyperphagia). 
 This scale was used in our study to assess the symptom severity 
of depressive episode and we ascertained that patient had reached 
euthymic state if HDRS score is <8(Hamilton Depression Rating 
Scale–17).42 
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III. Young Mania Rating Scale (YMRS) 
The Young Mania Rating Scale (YMRS) is used frequently to 
assess manic symptoms. This is a clinician rated scale. It takes 15-30 
minutes for administration. The scale consists of 11 items. Some of 
the items are graded on a 0 to 8 scale (thought content, irritability, 
speech and disruptive/aggressive behaviour), while the remaining 
seven items are graded on a 0 to 4 scale.  
This scale was used in our study to assess the symptom severity 
of manic episode and we ascertained that patient had reached 
euthymic state if YMRS score is <6.
43
 
 
IV. Lithium Knowledge Test Questionnaire (Tamil version) 
Peet and Harvey 
17 
devised Lithium knowledge test(LKT). 
Lithium Knowledge Test questionnaire is a brief questionnaire which 
identifies practical and pharmacological knowledge of patient which 
are very important in Lithium treatment if therapy is to be safe and 
effective. The original English version has been validated in 
psychiatric population and has shown good reliability. This scale has 
20 questions, 1 point is added for every correct response and 1 point is 
deducted for every wrong response. The total score of this 
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questionnaire is 20 points. Original version of this questionnaire also 
calculated LKT Hazard score which identifies aspects of intoxication 
symptoms about lithium.  
This scale has been adapted and validated in Tamil
8
, which can 
easily assess the knowledge of Lithium among patients in their native 
language. 
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Adaptation of LKT: 
In original English version most of the questions (5/7) had more than 
four options. One question had 11 options. All the questions had multiple 
correct responses. This original LKT was assessed by 6 psychiatrists 
(Professors: 3, Associate Professor: 1, Assistant Professors: 2). Face and 
content validity was assessed. Suggestions to improve the content to assess 
wide range of Lithium Knowledge among bipolar patient were obtained to 
improve its content validity. The following changes were made in the scale, 
as suggested by the group: 
 
 Technical terms and medical jargons were replaced with simple 
language, which was easy to understand by lay people 
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 Areas like efficacy, side-effects, toxicity and pregnancy were 
covered. 
 The format of questions was reframed. Each question had four 
options with one correct response among them. 
 Two questions eliciting adverse effects and toxicity symptoms alone 
had multiple correct responses. 
 One mark was given to each correct response. 
 The negative scoring for a wrong response was removed. 
 
 This modified Lithium Knowledge Test was translated into Tamil and 
back translated into English and this process was repeated until the questions 
in both the versions resulted in optimal word equivalence. 
 
Validation of modified LKT: 
This modified version was given to 
  1) Postgraduates in Psychiatry  
2) Nurses working in the psychiatry ward and 
3) Bipolar disorder patients on Lithium who are in euthymic state 
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It was assumed that postgraduates in psychiatry would have better 
knowledge about lithium than nurses and bipolar disorder patients. This 
scale was able to discriminate these 3 groups based on their lithium 
knowledge. Better Knowledge was seen among postgraduates in psychiatry 
(mean LKT=18.75, SD=1.91) followed by nurses working in psychiatry 
ward (mean LKT=10.73, SD=3.72) then bipolar disorder patients (mean 
LKT=5.83, SD=3.31). 
  
The Lithium Knowledge Test questionnaire Tamil version has 14 
items reflecting patient’s knowledge about Lithium therapy (treatment 
duration, effectiveness, monitoring). The last 2 questions have multiple 
correct responses which assesses knowledge about side effect and toxicity 
symptoms. Score was calculated by adding one point for every correct 
response. The maximum score is 21. 
 
After getting written informed consent, we administered Adapted 
Tamil version of Lithium Knowledge Test to patients (once they reached 
euthymic state as measured by HDRS/YMRS) and their primary care givers. 
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Figure 2: Methodology 
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    STATISTICS 
We carried out the statistical analysis using the software SPSS (IBM 
SPSS - Statistical Product and Service Solutions, version 19.0). We tested 
for normality of continuous variables using Shapiro-Wilks test. We used 
descriptive statistics to get the mean and standard deviation of variables like 
age, gender, education; occupation, income, marital status, substance abuse, 
family history, primary care giver and diagnosis of the participants. The 
mean age of onset, duration of illness, duration on lithium, number of 
episodes and number of hospitalizations were obtained. 
We estimated the mean LKT score for the patient group and care 
givers group separately. The percentages of individual items in the 
questionnaire were also calculated. We used ANOVA to test whether there 
was any difference in LKT scores between different categories of 
occupation, marital status and socio-economic status. Student t test was used 
to find out any difference in the mean LKT score between the 2 genders. 
Using Pearson correlation coefficient, we estimated the relationship between 
LKT score and age of the patient.  
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Relationship between LKT scores and Duration of illness, Duration of 
Lithium therapy, number of hospitalizations, number of episodes, age of 
onset of illness and number of years of education were assessed using 
spearman’s rho correlation. 
 We also used Pearson correlation coefficient to study the relationship 
between LKT scores of patient group and relative group. We did 
Multivariate linear regression analysis keeping LKT score as dependent 
variable and age of patient, number of years of education, age of onset of 
illness, number of episodes and care givers LKT score as independent 
variables. 
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RESULT 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3:CONSORT flow diagram 
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During our study period from May 2015 to August 2016 period 132 
bipolar disorder patients were admitted in the ward. Among them 93 were 
excluded according to the exclusion criteria. The remaining 39 patients on 
Lithium and their primary care givers were included in the study. Eight 
patients who were recruited did not come for follow up and hence their 
knowledge about lithium was not assessed. Three care givers did not consent 
for their assessment of Lithium Knowledge, but the corresponding patients 
consented for assessment and their data has been included for analysis. 
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Table 1: Sociodemographic profile 
 
Variable Number           Mean 
(n=39)(SD) 
Percentage   (%) 
 
Age 
 
 
                34.85 (12.33) 
 
 
Gender 
     Male 
     Female 
 
 
22 
17 
 
56.4 
43.6 
Education 
    Primary 
    High school 
    Higher secondary 
    Graduate 
 
 
4 
11 
7 
17 
 
10.3 
28.2 
17.9 
43.6 
Marital Status 
   Unmarried  
   Married 
   Separated  
 
15 
22 
2 
 
 
 
38.5 
56.4 
5.1 
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Substance Abuse 
   Alcohol  
   Smoking 
   Alcohol + smoking  
   Cannabis 
   None  
 
2 
3 
4 
3 
27 
 
5.1 
7.7 
10.3 
7.7 
69.2 
 
Occupation 
   Unskilled  
   Skilled  
   Unemployed  
   Homemaker  
   Student  
 
8 
18 
5 
6 
2 
 
20.5 
46.2 
12.8 
15.4 
5.1 
 
Income  
   Upper 
   Middle 
   Lower  
 
6 
24 
9 
 
15.4 
61.5 
23.1 
 
Family history 
   Present 
   Absent  
 
8 
31 
 
20.5 
79.5 
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Table 1 sets out the sociodemographic profile of these patients. 
Among these 39 patients 56.4% were males and 43.6% were females. The 
mean age of participants was 34.85(SD- 12.33). Most of the participants in 
our study were graduate 43.6% (n=17). Among the participants 30.8% 
(n=12) had history of substance use.  
Only 12.8% (n=5) were unemployed, the rest of the participants were 
employed in a skilled (n=18) or unskilled work (n=8), some were students 
(n=2) and others were functioning well as a home makers (n=6).  
Participants belonged to all Socioeconomic status-  15.4% were in 
upper, 61.5% were in middle and 23.1% were belonging to lower socio-
economic status.  
Family history of Psychiatry illness was present in 20.5% (n=8) and 
absent in remaining 79.5% (n=31). 
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Table 2: Care Givers of the participants 
Variable Number (n=39) Percentage   (%) 
Primary Caregiver 
  Mother 
  Father 
  Sibling 
  Spouse 
  Children 
 
 
8 
10 
3 
11 
7 
 
20.5 
25.6 
7.7 
28.3 
17.9 
Caregivers Education 
    Primary 
    High school 
    Higher secondary 
    Graduate 
 
12 
7 
12 
8 
 
30.8 
17.9 
30.8 
20.5 
 
Most of the primary care givers were parents – mother 20.5% (n=8) 
and father 25.6% (n=10) followed by children in 17.9% (n=7) of the 
participants. 
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Table 3: Diagnosis of the participants 
 
Diagnosis Total Number of 
patients (n=39) 
Percentage (%) 
 
Current episode 
   Mania  
   Depression 
 
36 
3 
 
92.3 
7.7 
 
Psychotic symptoms 
  Present 
  Absent 
 
14 
25 
 
35.9 
64.1 
 
Out of 39 patients 92.3% (n=36) participants had mania and 7.7% 
(n=3) participants had depression. Fourteen patients had psychotic 
symptoms in their mood episodes and twenty five patients had no psychotic 
symptoms (Table 3). 
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Table 4: Clinical Features of the Participants 
 
Variable 
 
Mean Standard deviation 
Age of onset   27.69 
 
9.18 
Duration of illness 
(in months) 
 
82.9 92.61 
Duration on Lithium 
(in months) 
 
20.59 20.32 
No. Of Episodes 
 
3.05 1.48 
No. of Hospitalization  
(in months) 
 
2.67 1.4 
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The mean age of onset of the participants in our study was 27.69 
years. 50% of our participants had illness before 25 years (Median = 25). 
The age of onset ranged between 14 years to 53 years.  
More than 50% of the participants had duration of illness less than 
5yrs (median = 54 months). The mean duration of illness was 82.9 months.  
About 50% of participants were on Lithium for a period of one 
year(median= 12 months). The mean duration of Lithium was 20 months.  
Number of episodes ranged from 1 to 8, with the mean number of 
episodes 3.05. The number of hospitalizations varied between 1 and 7. The 
mean no. of hospitalization was 2.67. 
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The mean lithium knowledge test score of patients was 9.5 
(SD=4.32). Among the relatives the mean lithium knowledge test score was 
8.5 (SD=4.65). 
 
Figure 4: Lithium knowledge test scores of patients and care givers 
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Table 5: Items in Lithium Knowledge Test Questionnaire and no. of 
participants giving correct responses: 
 
 
Items in Questionnaire 
 
Patients 
Knowledge 
n=31   (%) 
Care givers 
Knowledge 
n=36       (%) 
Acts as a mood stabilizer  
Drugs to avoid 
Avoid Lithium during diarrhoea and vomiting 
Monitor thyroid & kidney function 
S.Lithium 12 hrs after last dose 
Plan pregnancy after consulting with doctor 
Therapeutic level 
Duration of treatment 
Need for regular blood test 
Cannot conclude Lithium ineffective if relapse 
Lithium had been used for many years 
Avoid reduced salt intake and fasting  
 
11          28.2 
23          59 
17          43.6 
19          48.7 
22          56.4 
8            20.5 
13          33.3 
10          25.6 
19          48.7 
15          38.5 
15          38.5 
5            12.8   
14          35.9 
22          56.4 
22           56.4 
17           43.6 
21           53.8 
4             10.3 
14           35.9 
4             10.3 
20           51.3 
19           48.7 
12           30.8 
5             12.8 
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 About 59% (n=23) of the patients and56.4% (n=22) of the care givers 
knew that diuretics and certain painkillers like Aspirin, ibuprofen and 
diclofenac sodium should be avoided while taking Lithium. 
Around 50% of the participants knew about regular blood 
investigations to be done while taking Lithium. About 56.4% (n=22) of 
patients and 53.8% (n=21) of care givers knew that serum lithium test 
should be done 12 hrs after the last dose. Nineteen patients, 48.7% and 
seventeen caregivers, 43.6% care givers knew that thyroid and renal 
functions should be monitored during the course of Lithium. Nineteen 
patients, 48.7% and 20 patients, 51.3% care givers knew that serum lithium 
level should be monitored regularly. But only 33.3% (n=3) of patients knew 
that lithium is not effective when the blood level is low & has toxic effect 
when blood level is high.  
Very less number of participants 20.5% (n=8) and care givers 10.3% 
(n=3) knew that women taking lithium should consult their treating 
psychiatrist before planning for pregnancy.  
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  Only 28.2% (n=11) participants and 35.9% (n=14) care givers 
identified lithium as a mood stabilizer. Nine of the participant identified 
Lithium as a reassuring agent, 6 of them said Lithium is a sleeping pill and 2 
participants said Lithium is used to treat Lithium deficiency.   
 
Figure5: Lithium Knowledge Test Questionnaire: Patients knowledge 
about mode of action of Lithium 
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Only 43.6% (n=17) of the patients knew that Lithium should be 
stopped immediately and treating psychiatrist should be consulted during 
diarrhoea and vomiting. Three patients have said that Lithium should be 
continued in the same dose and nine patients have said fluids should be 
increased and Lithium should be continued in the same dose.  
 
Figure6: Lithium Knowledge Test Questionnaire: Patients knowledge 
about what should be done during diarrhoea and vomiting while taking 
Lithium 
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 Out of 31 participants 22 of them knew that serum Lithium test should 
be done 12 hrs after the last dose. Five of the patients wrongly said serum 
lithium levels should be done immediately after taking lithium. 
 
Figure7: Lithium Knowledge Test Questionnaire: Timing of blood 
investigation to check serum Lithium Level. 
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Ten patient (25.6%) and only four (10.3%) care givers said that 
Lithium is prescribed for several years. Eleven patients said that Lithium is 
prescribed only when psychologically unwell. Nine patients had said that the 
dose of lithium can be reduced after one year of symptom free period. 
 
Figure8: Lithium Knowledge Test Questionnaire: Patients knowledge 
Duration of Lithium Intake 
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Only 8 of the patients knew that women on Lithium should consult the 
treating psychiatrist before planning for pregnancy  
 
Figure 9: Lithium Knowledge Test Questionnaire: Patients knowledge 
about Lithium and Pregnancy 
 
 
 
 
8
23
n=31
Knowledge present
Knowledge absent
  
 
52 
 
 Nineteen patients identified that regular Lithium Test should be done 
to measure the amount of serum lithium level. Four patient wrongly said to 
check for anemia and 6 patients said to verify recurrence of disease. 
 
Figure10: Lithium Knowledge Test Questionnaire: Patients knowledge 
about the need for regular blood test 
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Table 6: Items in Lithium Knowledge Test Questionnaire- (Adverse 
Effects and toxicity symptoms) and no. of participants giving correct 
response: 
 
Items in Questionnaire 
 
Patients 
Knowledge 
n=31   (%) 
Care givers 
Knowledge 
n=36       (%) 
Adverse Effects 
Acne 
Frequent intake of water 
Mild tremors 
Frequent urination 
Thyroid function suppression 
 
Lithium Toxicity Symptoms 
Severe tremors 
Vomiting  
Confusion 
Abdominal pain  
 
11         28.2 
18         46.2 
19         48.7 
16         41 
14         35.9 
 
 
14        35.9 
9          23.1 
11        28.2 
8          20.5 
 
11          28.2 
17          43.6 
24          61.5 
14          35.9 
17          43.6 
 
 
17          43.6 
10          25.6 
15          38.5 
12          30.8 
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Figure 11: Lithium Knowledge Test questionnaire – Knowledge about 
adverse effects of Lithium 
  
Only less than 50 % of the patients and care givers knew about the 
toxicity symptoms of Lithium. But about 48.7% (n=19) of patients and 
61.5% (n=24) care givers knew that Lithium can cause mild tremors. 
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Figure 12: Lithium Knowledge Test questionnaire – Knowledge about 
Toxicity symptoms of Lithium 
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Only less than 50% of the participants knew about the toxicity 
symptoms of Lithium. The following number of patients knew about toxicity 
symptoms- 
- 35.9% (n=14) knew about severe tremors;  
- 23.1% (n=9) knew about vomiting;  
- 28.2% (n=11) knew about confusion and  
- 20.5% (n=8) patients knew that abdominal pain is one of the symptom 
of Lithium toxicity.  
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Table 7: Correlation of LKT score with Sociodemographic profile 
 
Patient’s  LKT score 
compared with 
 
Mean of LKT 
scores 
                 df          p value 
Age of the patient 
 
 Pearson correlation=-0.384 
p=0.033 
Gender 
Male  
Female 
 
8.83(4.35) 
10.46(4.27) 
 
t =-1.035        29            0.309 
 
No. of years of 
Education 
 
 Spearman’s rho correlation= 
0.487                     p=0.005 
Occupation 
   Unskilled  
   Skilled  
   Unemployed  
   Homemaker  
   Student 
 
7.67(3.32) 
9.44(4.44) 
9.67(7.50) 
11(3.91) 
12.5(2.12) 
 
 
F=0.598           4            0.668 
Marital Status 
   Unmarried  
   Married 
   Separated 
 
9.85(4.27) 
8.63(4.30) 
14.5(0.70) 
 
 
F=1.794           2            0.185 
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Socioeconomic status 
  Upper 
  Middle 
  Lower  
 
11.4(4.72) 
9.6(4.1) 
7.2(4.7) 
 
F=1.213      2           0.312 
 
 
Lithium Knowledge test scores were compared with various 
sociodemographic variables. Lithium Knowledge test scores were negatively 
correlated with age which was statistically significant, p=0.033 (younger 
patients had higher scores than elderly patients).  
Gender did not have any statistical difference in the LKT scores. The 
means LKT score among males were 8.83 and female were 10.46.  
Number of years of education positively correlated with the LKT 
scores and the p value was significant (p=0.005).  
Occupational and marital status did not have any correlation with the 
Lithium Knowledge. The mean values of LKT scores were increasing as the 
socioeconomic status increased ( Upper SES- 11.4, Middle SES- 9.6, Lower 
SES- 7.2) but it was not statistically significant(p=0.312). 
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Table 8: Correlation of LKT scores with other variables 
Patient’s LKT score 
compared with 
Correlation coefficient P value 
Age of onset 
Duration of illness 
Duration on Lithium 
No. of Hospitalization  
No. of Episodes 
 
Spearman’s rho correlation= - 0.373                          
Spearman’s rho correlation= 0.26 
Spearman’s rho correlation= 0.31 
Spearman’s rho correlation= 0.332 
Spearman’s rho correlation= 0.39 
0.039
0.89 
0.091                     
0.068 
0.026 
 
 
Age of onset of Bipolar illness had a positive correlation with the 
mean Lithium Knowledge test score (p=0.039).Lithium Knowledge test 
score was more in participants who had more number of episodes when 
compared with participants with less number of episodes. P value was 
significant at 0.026.  
Other variables like duration of illness, duration on Lithium and 
number of hospitalization did not have significant correlation with lithium 
knowledge test scores. 
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   Table 9: Correlation of patient’s LKT score with care givers LKT 
score 
Patient’s  score compared with Pearson correlation 
Care givers score 0.465                        p=0.013 
 
When patients lithium Knowledge test scores were compared with 
care givers score, there was a positive correlation which was statistically 
significant (p=0.013). 
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Table 10: Multivariate Linear Regression analysis 
 
Variable 
 
B 
Standard 
Error 
 
T 
 
P value 
 
Age of patient 
No. of years of Education 
Age of Onset 
No. Of Episodes 
Care giver LKT score 
 
-0.201 
0.165 
0.106 
1.482 
0.217 
 
0.103 
0.214 
0.122 
0.662 
0.163 
 
-1.953 
0.773 
0.865 
2.238 
1.328 
 
0.064 
0.448 
0.396 
0.036 
0.198 
 
Linear Regression analysis was done between lithium Knowledge test 
score and variables like Age of patient, number of years of Education, Age 
of Onset of illness, number of episodes and Care giver LKT score. In this 
multivariate analysis of various parameters, only Number of episodes was 
statistically (p=0.036) significant with the LKT scores. 
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DISCUSSION    
In our study most of the patients had a diagnosis of Mania 92.3% 
(n=36) when compared to depression 7.7% (n= 3). This may be because we 
included only patients who got admitted in the ward.  Knowledge about 
lithium therapy among patients and their caregivers was below average in 
our study. The mean of lithium knowledge test score of patients was 9.5 
(SD=4.32) and care givers was 8.5 (SD=4.65) when the maximum that can 
be scored on Lithium Knowledge test is 21. 
 
Mean age of the patients and mean age of onset of illness had a 
negative correlation with the Lithium Knowledge test score. Number of 
years of education and number of episodes had a positive correlation with 
the Lithium Knowledge Test scores. Mean Lithium Knowledge test scores of 
patients and their care givers score were positively correlated. 
 
The mean of Lithium Knowledge test scores among patients and their 
care givers was less than 50% of the total score of 21 (patients = 9.5 and 
care givers = 8.5) . Though these patients were on Lithium for many years 
their knowledge was far from adequate. A similar study which used German 
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Translation of Lithium Knowledge test questionnaire for assessing Lithium 
Knowledge also showed poor knowledge among patients taking Lithium
34
.  
 
Another study which was done using Portuguese version of Lithium 
Knowledge test questionnaire in one hundred six patients with diagnosis of 
bipolar disorder I or bipolar disorder II according to DSM-IV criteria and on 
lithium treatment (for at least one month) also reflected poor knowledge 
about Lithium. The mean of total score LKT of bipolar patients in that study 
was 9.0 (SD=0.75) for men and 8.74 (SD=0.44) for women
35
. Literature 
shows patients as well as their family members had little knowledge about 
the medications prescribed to patients, which limits their ability to maintain 
therapeutic drug levels which is mandatory in Lithium therapy
36
 
 
When we analyzed each items in the questionnaire. Only 28.2% 
(n=11) of patients and 35.9% (n=14) of care givers identified Lithium as 
mood stabilizers. Nine of the participant identified Lithium as a reassuring 
agent, six of them said Lithium is a sleeping pill and two participants said 
Lithium is used to treat Lithium deficiency. More than 50% of patients and 
care givers were aware about the drugs (pain killer and diuretics) to be 
avoided while taking Lithium (Patients=59%, Care givers=56.4%).  
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Only 43.6% (n=17) of patients knew that Lithium should not be taken 
during diarrhoea and vomiting. Three patients have said that Lithium should 
be continued in the same dose and nine patients have said fluids should be 
increased and Lithium should be continued in the same dose. This finding 
was alarming because more than 50% of participants were not aware about 
what to do during diarrhoea and vomiting which is a common medical 
ailment, which can lead to fluid loss in body and ultimately can result in 
Lithium toxicity. 
 
About 56.4% (n= 22) of patients and 53.8% (n=21) of care givers 
were aware that serum lithium test should be done 12 hours after the last 
dose, which may be due to repeated serum Lithium level monitoring. But 
only 48.7% patient knew that blood investigations were done to monitor 
Thyroid function, Kidney function and Lithium level in blood. Only 33.3% 
(n=13) of participant and 35.9% (n=14) of care givers knew that Lithium is 
not effective when Lithium blood levels is too low and has toxic effects 
when blood level is too high.  
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Ten patient (25.6%) and only four (10.3%) care givers said that 
Lithium is prescribed for several years. Eleven patients said that Lithium is 
prescribed only when psychologically unwell. Nine patients had said that the 
dose of lithium can be reduced after one year of symptom free period. This 
poor knowledge about the duration of Lithium treatment can result in poor 
compliance among patients and relapse of symptoms.  
 
Very less number of patients 20.5% (n=8) and care givers 10.3% 
(n=4) knew that women on Lithium should consult the treating Psychiatrist 
before planning pregnancy. Less than 50% of patients and care givers were 
aware about adverse effects and symptoms of toxicity of lithium. This lack 
of Knowledge can increase the risk of toxicity, particularly with a drug like 
lithium, which has a narrow therapeutic range and severe toxic effects. The 
relationship between lack of knowledge and risk of toxicity with Lithium 
therapy has also been highlighted in American psychiatry association 
guidelines. 
37 
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We studied the association of age compared with their Lithium 
Knowledge Test scores. Results showed that age of the patient had a 
negative correlation with the Lithium Knowledge Test scores with a 
significant p value of 0.033. This finding reflects that Lithium Knowledge 
was less among elderly age group patient. In a study which studied patients’ 
Knowledge about Lithium Therapy in the Elderly showed mean Lithium 
Knowledge test score of 4.45.This study also looked for mean LKT hazard 
score which was also less 5.85, which was suggestive of potentially 
hazardous lack of knowledge about Lithium. There was also a significant 
negative correlation between the LKT score and Lithium hazard score (r = 
−0.65, P< .01 [1-tailed]) in that study.2These findings suggest poor 
knowledge about lithium therapy among elderly age group which is in 
accordance with our study. This poor knowledge of lithium could also 
contribute to lithium toxicity. 
 
 Another study done by Schaub, et al.,(2001) also showed age had 
inverse association with the lithium Knowledge
34
. There are many trials 
which had studied about the effects of Lithium in elderly which was 
prescribed for treatment-resistant depression. All these trials have 
highlighted consistently that elderly age group are at high risk for 
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neurotoxicity when compared with young adults
38, 39, 40
. Less knowledge of 
Lithium among elderly increases the risk of neurotoxicity even more. 
 
Sociodemographic variables like gender, occupational status and 
marital status did not have any correlation with the lithium Knowledge Test 
scores. Another study which was done to determine the knowledge level of 
Lithium in patient who are taking it and factors which were associated with 
the Lithium Knowledge among 123 lithium out-patient clinic, also showed 
no association between Lithium Knowledge and gender of patients
34
. Also 
there were no association of Lithium Knowledge with duration of treatment, 
education and diagnosis in that study.  
 
Though the mean LKT scores showed an increasing trend from lower 
to upper socioeconomic status (Upper SES - 11.4, Middle SES - 9.6, Lower 
SES - 7.2) the p value was not significant p=0.312. Number of years of 
education had a significant positive correlation (p= 0.005) with Lithium 
Knowledge Test scores in our study. This may contribute to better treatment 
adherence and less relapse rate among educated patients. A study done by 
Colom, et al.,(2003) showed educated patient with bipolar affective disorder 
patients showed lower relapses rates, lower number of hospitalizations.
15
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 Age of onset of illness had a significant Spearman’s rho correlation 
with the Lithium Knowledge Test scores, p value was 0.039. Patients with 
more number of episodes of illness had better Knowledge about Lithium 
therapy than the patient with less number of episodes. The p value was also 
significant 0.026. But the number of hospitalization did not have any 
correlation with the Lithium knowledge. In our study, the duration on 
lithium did not have any correlation with Lithium Knowledge test score 
(p=0.091). This means, knowledge about lithium did not differ between 
patients who were on lithium for 1 month and 60 months. 
 
In patients who had high Lithium Knowledge Test scores also had 
higher LKT scores in their care givers. There is a direct correlation between 
patient’s knowledge and care givers knowledge, and p value was 0.013 
which is significant. Ours was the first study which also assessed for 
Lithium Knowledge among primary care givers. In our country the role of 
primary care giver is enormous in various treatment phases like acute and 
maintenance treatment. So the knowledge of the primary care giver is also 
equally important as the patients to prevent further relapse. Our study 
showed a significant positive correlation between patient’s knowledge and 
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their care giver’s knowledge. The clinical implication is by improving the 
knowledge about illness and treatment among relatives, patients’ knowledge 
can also improve and vice versa. So when patient is acutely ill relatives can 
be given structured educational program regarding the illness and lithium 
therapy which can improve their Lithium knowledge and there by 
compliance of patient. 
 
Structured questionnaire which can assess various domains of lithium 
knowledge may be useful in clinical practice. One such questionnaire is 
Lithium Knowledge test Questionnaire (LKT). LKT is a rapid and reliable 
instrument which is as effective as a lengthier standard interview scale. It 
has a high level of acceptability among lithium patients.
41
 This Lithium 
knowledge test questionnaire which is used in our study is a self-
administered questionnaire which can be easily administered. It takes less 
than 10 minutes for administration. The questions are in simple language so 
it can be easily understood and answered by the patients and their care 
givers. The LKT scale assesses knowledge about lithium interactions, food 
and lithium, risks of intoxication, necessity of measuring lithium levels, 
continuation of the lithium dosages, side effects and toxicity symptoms of 
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lithium pharmacology
11
. This questionnaire can be used in regular basis to 
assess Lithium Knowledge among bipolar patients in a structured way. 
 
Lithium Knowledge Test questionnaire can aid the clinician for better 
understanding of the difficulties that bipolar affective disorder patients have, 
and offer specific information during clinical consultations. Identification of 
problems about lithium treatment and bipolar disorder can contribute to 
good treatment outcome. One of the good predictor of the adherence rates in 
bipolar patients is their knowledge level which is in accordance with past 
studies.
13
 
 
Our study results highlight the need for structured assessment about 
lithium knowledge among patient on Lithium and their care givers to find 
out the lacunae in knowledge. Appropriate educational program about action 
of lithium, duration of treatment, blood parameters to be monitored, lithium 
and pregnancy, drug to avoid when taking lithium, adverse effects and 
toxicity symptoms should be given  for patients who are initiated on lithium 
and their care givers. This education should be repeated at regular intervals 
for patients on long term Lithium. Literature shows that patients who have 
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been on lithium for a long time did not receive education about lithium 
therapy when compared with patients who are newly commenced on 
Lithium treatment
14
.Past studies have highlighted that the number of 
relapses, recurrences, number and length of hospitalizations per patient was 
significantly less in psychoeducation group when compared with patients 
who did not receive any psychoeducation program
15
. Psychoeducation not 
only provides information to patients but also has shown to stabilize lithium 
plasma levels by improving pharmacological treatment adherence. 
15 
 
 
 
 
 
 
 
 
 
 
  
 
72 
 
STRENGTHS 
 
 This is the first study done in India assessing Lithium Knowledge 
among Bipolar disorder patients. 
 We also estimated the knowledge of lithium therapy among primary 
care givers using the same scale as the role of care givers plays an 
important role in maintaining euthymic state among the patients. 
 We used our validated and locally adapted Tamil version of Lithium 
Knowledge test questionnaire. 
 We assessed whether various sociodemographic variables like Age, 
Gender, Education, Marital status, substance abuse, occupation, and 
socioeconomic status can influence the knowledge of lithium. Other 
clinical variable like Age of onset, duration of illness, duration on 
lithium treatment, number of episodes and number of hospitalization 
were also assessed for correlation with lithium knowledge test scores. 
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LIMITATIONS 
 
 The sample size was small in our study. Future study can be done with 
larger sample size to look for correlation between various 
sociodemographic and clinical variables. 
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CONCLUSION 
Our study highlights various important finding about the knowledge on 
Lithium therapy among patients with bipolar disorder: 
 
 Knowledge about lithium among bipolar patients and their care givers 
is far from adequate. The mean score was less than 50% of the total 
score 
 Age of the patient was negatively correlated with the Lithium 
Knowledge level. 
 Number of years of education had significant positive correlation with 
the lithium knowledge. 
 Patients with early age of onset of illness had better lithium 
knowledge when compared with patients with later age of onset. 
 Lithium Knowledge was better among patients with more number of 
episodes than in patients with lesser number of episodes. 
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 Socioeconomic status, duration of illness, duration on lithium and 
number of hospitalization had no influence on the knowledge. 
 Good knowledge about lithium in care givers seems to influence 
knowledge among patients. 
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FUTURE DIRECTIONS 
 
 To continue the study with larger sample size. 
 To include educational program along with regular routine clinical 
check-ups and education by the primary treating psychiatrist and 
assess whether extra educational program can  
- Increase the knowledge about lithium  
- Increase the drug compliance   
- Decrease the relapse and recurrence rate  
- Decrease the number of hospitalization  
- Increases the duration of euthymic period 
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    ANNEXURE 
 
PATIENT PROFORMA 
 
S.no:         
Name:        IP No: 
Age:                              Sex:    OP No: 
Education:         Illiterate / Primary / Secondary / Higher secondary/ Graduate 
Marital Status:  Unmarried / Married / Divorced / Widow / Not legally separated                                           
Substance use:  Alcohol / Smoking / Others 
Occupation:       Unskilled/ Skilled/ professional/ homemaker/ Not Employed 
Total Monthly Income:  Upper (>5357) / Middle / Lower (<811) 
Primary care giver:  
Family History: 
Past history:                     Age of onset- 
                    Diagnosis- 
                                     Psychotic symptoms-  
                                       Duration of illness- 
                                    No. of hospitalization-   
                                       No. of Episodes-          
 
Baseline HAMD/YMRS score current episode: 
Duration on Lithium:               Dose at discharge: 
Lithium level at discharge: 
Current episode: 
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LITHIUM KNOWLEDGE TEST 
Mark the right answer for the following questions. 
1) In your opinion, lithium acts  
a. As a reassuring agent. 
b. As a mood stabilizer. 
c. As a sleeping pill. 
d. As a treatment for lithium deficiency. 
 
2) What you should not do while taking lithium? 
a. Taking medications for cough. 
b. Taking diuretics and certain painkillers like Aspirin, Diclofenac 
sodium , Ibuprofen. 
c. Exposure to very cold climates. 
d. Taking antibiotics for infections. 
 
3) If you suffer from acute diarrhoea and vomiting, what would you 
do? 
a. Stop taking lithium immediately and consult your doctor. 
b. Increase lithium dosage. 
c. Continue lithium as it is. 
d. Take fluids, but don’t stop lithium. 
 
4) While on lithium, it is necessary to monitor: 
a. Gallbladder function. 
b. Frequent blood glucose level. 
c. Thyroid gland and kidney function. 
d. Cardiac function. 
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5) Which of the following statement is true? 
a. Blood for lithium test should be given immediately after taking 
lithium. 
b. Lithium predisposes to urinary tract infection. 
c. Serum lithium test should be done 12hrs after the last dose. 
d. If you feel good, you can skip few doses of lithium. 
 
6) Women on lithium: 
a. May experience menstrual irregularities. 
b. Should get pregnant after consulting your doctor. 
c. May experience headache during menstruation. 
d. Can have delayed menopause. 
 
7) Which of the following statement is true? 
a. If you have sleep disturbance, you can increase the dosage of 
lithium. 
b. Lithium is not effective when the blood level is too low and has 
toxic effects when blood level is too high. 
c. Lithium increases the energy of the body and mind. 
d. Extra doses of lithium should be taken if you feel depressed. 
 
8) Which of the following statement is correct? 
a. Lithium is prescribed only when you are psychologically unwell. 
b. Often, lithium is prescribed for several years. 
c. Dose of lithium can be reduced after one year of symptom free 
period. 
d. Lithium has been replaced by modern and effective drugs. 
 
 
 
 
 
  
 
89 
 
9) Why regular blood tests are needed? 
a. To measure the amount of lithium in blood. 
b. To check for anaemia. 
c. To check lipid level. 
d. To verify the recurrence of the disease. 
 
10) True about lithium: 
a. We can’t conclude that lithium is not effective for the individual 
if a relapse happens while on lithium. 
b. Patients with diabetes should not take lithium. 
c. Lithium causes vitamin deficiency . 
d. Lithium predisposes to excessive tears. 
 
11) Which among the following is correct? 
a. Lithium is the newly available drug in market as a mood 
stabilizer. 
b. Lithium has been tried & tested for many years. 
c. Elderly patients are not sensitive to develop side effects. 
d. Lithium is not freely available in India. 
 
12) When you are taking lithium, which should be avoided in your 
diet? 
a. Butter and ghee. 
b. Reduced salt intake and fasting. 
c. Coffee & tea. 
d. Spicy items. 
 
 
 
 
 
  
 
90 
 
NOTE: The following 2 questions have more correct answers. Tick all the 
correct answers 
13) Which are all the side effects of lithium? 
a. Pimples. 
b. Sleeplessness. 
c. Constipation. 
d. Frequent intake of water. 
e. Mild tremors. 
f. Excessive salivation. 
g. Giddiness. 
h. Frequent urination. 
i. Thyroid function suppression. 
 
14) Which are all lithium toxicity symptoms? 
a. Severe tremors. 
b. Headache. 
c. Vomiting. 
d. Palpitations. 
e. Confusion. 
f. Chest pain. 
g. Abdominal pain. 
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M a ;ths hpd; i f na hg ;g k ;  : 
Nj j p      : 
 
M a ;T f ;Fl;g L g thpd; xg ; Gj y ; : 
 
 
 
 
ehd; ,e;j  M uha ;r;rpa pd; Nehf ;f k ; k w ;W k; mj d; g a d;g hl;bi dg ;  g w;w p nj s pthf T k ;. 
T ps f ;f k hf T k ; nj hpa g;g L j;j g ;g lL s ;Ns d;.  ,e;j  M uha ;r;rpa py ; g q ;F nf hs ;s T k ;.  ,e;j  
M uha ;r;rpa pd; k Uf ; Jt  hPj pa hd Fw pg ;Gf i s  tUk ; f hy j ;j pY k; cg Na hf g lg L j ;j pf ; 
nf hs ;s T k ; K O k dJld; rk ;k j pf ;f pNw d;.    
 
 
M a ;T f ;Fl;g L g thpd;  ng a H. K f tup  :  
 
 
 
 
       i f na hg;g k ;    : 
 
 
    Nj j p    : 
 
cldpUg ;g thp d;  i f na hg ;g k ;   : 
 
Nj j p    : 
 
 
 
 
 
 
 
 
 
 
M a ;ths hpd; nj hi y Ng rp v z ;   :  
 
new pK i w  FO mY ty f  nj hi y Ng rp v z; : 042 2 – 257 01 70  cs ; nj hlHG v z ;  : 5818  
 
 
 
 
 
y pj ;j pa k ; G y i k; ;; ;; ;  N jH T 
 
f Po ;f z ;l tpdhf ;f S f ;F  rhpa hd tpi li a  ms pf ;f T k ; 
1 cq ;f s ; f Uj ;j pd;g b y pj ;j pa k; v g ;g b Nti y  nra ;f pw J?  
1. k depi y i a  cW j pgL j;Jf pw J  
2. k depi y i a  epi y g;g L j;JtJ ( rk d;nra ; t J)  
3. J}f ;f k ; tui tj ;j y ; 
4. y pj ;j pa k ; Fi w g hl;i l rhpnra ;f pw J  
 
2 y pj ;j pa k; cl;nf hs ;S k ; ng hOJ v tw ;i w  nra;a f ;$lhJ?  
 1. ,Uk y ; k Ue;Jf s ; v L f ;f f ;$lhJ 
 2. i lA+ul;bf ; k w ;W k ; rpy  ty pk hj ;j pi uf s; cl;nf hs ;S jy ; (Aspirin,   
                Diclofenac Sodium, Ibuprofen) 
 3. Fs ph;f hy q ;f s py ; nts pNa  nry ;Y j y ; 
4. M d;bg a hl;bf ; (antibiotics) cl;nf hs ;S j y ; 
 
3 the;j p k w ;W k; ta pw ;W g ;Ng hf ;F V w ;g l;lhy ; v d;d nra ;tPHf s ;?  
 1. y pj ;j pa k ; k hj;j pi uia  cldba hf  epW j ;j ptpl;L  k Uj ;Jti u mZFj y ; 
 2. y pj ;j pa k ; ms i t mj pf g ;g L j;Jj y ; 
3. y pj ;j pa k ; k hj;j pi uia  mg ;g bNa  nj hlHe;J  cl;nf hs ;S jy ; 
4. y pj ;j pa j;i j  epW j;j hk y ; mj pf  ePH M f huq ;fs ; cl;nf hs ;S j y ;.  
 
4. y pj ;j pa k; cl;nf hs ;S k ;  Ng hJ f z ;f hz pf ;f  Ntz ;ba i t 
 1. g pj ;j g ;i g  nra y;g hL  
2. ,uj ;j j ;j py ; rHf ;f i u ms T  
3. i j uha ;L  kw;W k ; rpWePuf k ; nra y ;g hL  
4. ,Uj a  nra y ;g hL  
 
 
 5. ,tw ;w py ; v e;j  thf ;f pa k ; cz ;i k a hdJ? 
 1. y pj ;j pa k ; ms T  Nrhj i df ;F  y pj;j pa k ; cl;nf hz ;lT ld; ,uj ;j k ;  
       nf hL f;f  Nt z ;L k; 
 2. y pj ;j pa k ; rpW ePHg ;g hi j a py ; f pW k pf s; % y k; V w ;g L k; g hj pg;i g  cz ;lhf ;f y hk ; 
 3. y pj ;j pa k ;  cl;nf h z ;l 12 k z p Neuk j ;j pw ;F g pw F ,uj;j j ;j py ; y pj ;j pa k;          
        ms i t Nrhj i d nra ;a  Ntz ;L k; 
 4. k depi y  ed;w hf  , Ue;j hy ; mt; tg ;Ng hJ y pj ;j pa k;  
        cl;nf hs ;S j i y  epW j;j pf ;nf hs ;s y hk ; 
 
6 ng z ;f s ; y pj;j pa k ; cl;nf hs ;S k ;  ng hOJ 
 1. k hj tplha ; Nf hs hW f s ; V w;g ly hk ; 
 2. k Uj ;JtUl d; f y e;j hNy hrpf ;f hk y ; f Hg k ht i j  j tpHj;j y; 
 3. k hj tplha pd; ng hO J j i y ty p Vw;g ly hk ; 
 4. k hj tpy f ;F epw ;w y ; j s ;s pg ;Ng hf y hk ; 
 
7 ,tw ;w py ; v i t cz;i k ?  
 1. J}f ;f k ; g hj pj ;j hy ; y pj ;j pa k; ms i t mj pf g ;g L j;j y hk ; 
 2. y pj ;j pa k ; ,uj;j j ;j py ; Fi w thf  ,Ue;j hy ; g a d; ,Uf;f hJ ;  mj pf k ;  
        ,Ue;j hy ; er; Rj ;j d;i k  Vw ;g l;L tpL k; 
 3. y pj ;j pa k ; cly ; k w;W k; k dj pd; rf ;j pi a  mj pf g ;g L j;Jf pw J  
 4. k dr;Nrh Htp d; ng hO J y pj ;j pa k; mj pf  ms tpy ;  cl;nfhs ;s y hk ; 
 
8 ,tw ;w py ; cz ;i k  thf;f pa k ; v J? 
 1. y pj ;j pa k ; k depi y  rhpa py ;y hj  Ng hJ k l;L k ; cl;nf hs;s  Ntz ;L k ; 
 2. y pj ;j pa k ; k hj;j pi u g y  tUlq ;f S f ;F cl; nf hs ;s  Ntz ;L k ; 
3.; xU tUlj ;j pw ;F  Ne ha ; mw pFw p ,y ;i y nad;w hy ; y pj ;jpa k; ms i t  
  Fi w f;f y hk ; 
4. y pj ;j pa k ; k hj;j pi uia  tpl Gj pa  g a D s;s  k Ue;Jf s ; cs;s d  
 9 ,uj ;j g ; g hpNrhj i d V d; Nj i t?  
 1. y pj ;j pa k ; k hj;j pi u ms i t f z ;lw pa  
 2. ,uj ;j Nrhi f  f z ;lw pa  
 3. nf hOg ;Grj ;J mf pf k hti j  mw pa 
 4. Neha ; k Pz ;L k ; te;J s ;s j h v d;W  f z;lw pa  
 
10  ,tw ;w py ; cz ;i k  thf;f pa k ; v J? 
 1. y pj ;j pa k ; cl;nf hs ;S k ; Ng hJ Neha ; k Pz ;L k ; V w;g l;lhy ; y pj ;j pa k ;  
       Nti y nra ;a tpy ;i y  v d;W  cWj pa hf  $w K ba hJ 
 2. rHf ;f i u Neha ; cs ; s tHf s ; y pj ;j pa k ; v L f;f f ;$lhJ  
 3. y pj ;j pa k ; tpl;lk pd; (vitamin) Fi w g hL f i s V w ;g L j;Jk ; 
 4.; y pj ;j pa k ; f z;z py ; mj pf ePH tbj i y  cz ;lhf ;Fk ; 
 
11  ,tw ;w py ; cz ;i k  thf;f pa k ; v J? 
1. y pj ;j pa k ; Gj pj hf  mw pK f k; nra ;a g ;g l;l k Ue;J  
2. y pj ;j pa k ; g y  M z;L f s hf  ,e;Ne ha ;f ;F nf hL f ;f g ;g l;L  tUk ; k Ue;J 
3  ta j hdtHf S f ;F y pj ;j pa k; k hj ;j pi ua pd; g f ;f tpi s T  tuhJ 
4  y pj ;j pa k; ,e;j pa htp y ; g y  ,lq;f s py ; f pi lg ;g j py ;i y 
 
12  y pj ;j pa k; cl;nf hs ;N th H NrHf ;f $lhj  cz T f s ; 
 1. nea ; ntz ;nz a ; 
 2. Fi w thd ms T  cg ;G cl;nf hs ;S j y ; k w;W k; tpuj k ; ,Uj ;j y ; 
 3. f hg p k w ;W k; Nj ePH  
 4. f huk hd cz T f s ; 
 
 
 
 
  
( f Po ;f z ;l Nf s ;tpf s py ; xd;W f ;Fk ; mj pf k hd tpi lf s ; cs ;s d rhpa hd tpi lf s ; 
mi dj ;i j Ak; Fw pg ;g pL f )  
13  y pj ;j pa k; k hj ;j pi ua pd; g f ;f tpi s T f s ; 
 1 K f g ;g Uf ;f s ;  
 2. J}f ;f k ; g hj pj ;j y; 
 3. k y r;rpf ;f y ; 
 4. j hf k ; 
 5. cly ; i f  eL f;f k ; ( Ny rhd)  
 6. mj pf  v r;rpy ; C W jy ; 
 7  j i y Rw;w y ; 
 8. mbf ;f b rpW ePH f o pj ;j y ; 
 9 i j uha ;L  g pur;rpi df s ; 
 
14  y pj ;j pa k; er;Rj ;j d;i k a pd; mw pFw pf s ;  
 1. cly ;  eL f ;f k ; 
 2. j i y ty p 
 3. the;j p  
 4. g lg lg ;G 
 5. Fo g ;g k ; 
 6. neQ ;Rty p  
 7  ta pw ;W ty p 
 
 
 
 
 
 
 
 
1.   Depressed Mood      
      (sadness, hopeless, helpless, worthless) 
0     Absent 
1     These feeling states indicated only on questioning 
2     These feeling states spontaneously reported verbally 
3     Communicates feeling states nonverbally, i.e., through facial  
        expression, posture, voice and tendency to weep 
4      Patient reports VIRTUALLY ONLY these feeling states in his  
    spontaneous verbal and nonverbal communication 
 
2. Feelings of Guilt 
0     Absent 
1     Self-reproach, feels he has let people down 
2 Ideas of guilt or rumination over past errors or sinful deeds 
3 Present illness is a punishment.  Delusions of guilt 
4 Hears accusatory or denunciatory voices and/or experiences 
threatening visual hallucinations 
 
3. Suicide 
0     Absent 
1     Feels life is not worth living 
2 Wishes he were dead or any thoughts of possible death to self 
3 Suicide ideas or gesture 
4 Attempts at suicide (any serious attempt rates 4) 
 
4.    Insomnia - Early 
0 No difficulty falling asleep 
1 Complains of occasional difficulty falling asleep i.e., more than 
½ hour 
2 Complains of nightly difficulty falling asleep 
 
5.    Insomnia - Middle  
0 No difficulty 
1 Patient complains of being restless and disturbed during the 
night 
2 Waking during the night – any getting out of bed rates 2 
(except for purposes of voiding) 
 
6.    Insomnia - Late 
0 No difficulty 
1 Waking in early hours of the morning but goes back to sleep 
2 Unable to fall asleep again if gets out of bed 
 
7.    Work and Activities 
0 No difficulty 
1 Thoughts and feelings of incapacity, fatigue or weakness 
related to activities; work or hobbies 
2 Loss of interest in activity; hobbies or work – either directly 
reported by patient, or indirect in listlessness, indecision and 
vacillation (feels he has to push self to work or activities) 
3 Decrease in actual time spent in activities or decrease in 
productivity.  In hospital, rate 3 if patient does not spend at 
least three hours a day in activities (hospital job or hobbies) 
exclusive of ward chores. 
4 Stopped working because of present illness.  In hospital, rate 4 
if patient engages in no activities except ward chores, or if 
patient fails to perform ward chores unassisted. 
 
8.    Retardation 
       (slowness of thought and speech; impaired ability to concentrate;  
       decreased motor activity) 
0 Normal speech and thought 
1 Slight retardation at interview 
2 Obvious retardation at interview 
3 Interview difficult 
4 Complete stupor 
 
 
 
 
 
 
9.   Agitation 
0 None 
1 “Playing with” hand, hair, etc. 
2 Hand-wringing, nail-biting, biting of lips 
 
10.  Anxiety - Psychic 
0 No difficulty 
1 Subjective tension and irritability 
2 Worrying about minor matters 
3 Apprehensive attitude apparent in face or speech 
4 Fears expressed without questioning 
 
11.  Anxiety - Somatic 
       0     Absent      Physiological concomitants of anxiety such as:  
       1     Mild      Gastrointestinal - dry mouth, wind, indigestion, 
    2     Moderate      diarrhea, cramps, belching 
       3     Severe      Cardiovascular – palpitations, headaches 
4     Incapacitating  Respiratory - hyperventilation, sighing 
                                Urinary frequency 
                                Sweating 
 
12.  Somatic Symptoms - Gastrointestinal 
0 None 
1 Loss of appetite but eating without staff encouragement.  
Heavy feelings in abdomen.   
2 Difficulty eating without staff urging.  Requests or requires  
laxatives or medications for bowels or medication for G.I.  
symptoms.  
 
13.  Somatic Symptoms - General 
0 None 
1 Heaviness in limbs, back or head, backaches, headache, 
muscle aches, loss of energy and fatigability 
2 Any clear-cut symptom rates 2 
 
14.  Genital Symptoms 
       0     Absent          0     Not ascertained 
       1     Mild                      Symptoms such as:  loss of libido, 
       2     Severe                 menstrual disturbances 
 
15.  Hypochondriasis 
0 Not present 
1 Self-absorption (bodily) 
2 Preoccupation with health 
3 Frequent complaints, requests for help, etc. 
4 Hypochondriacal delusions 
 
16.  Loss of Weight 
       A.    When Rating by History: 
0      No weight loss 
1      Probable weight loss associated with present illness 
2      Definite (according to patient) weight loss 
 
   B.   On Weekly Ratings by Ward Psychiatrist, When Actual  
          Changes are Measured:  
0 Less than 1 lb. weight loss in week 
1 Greater than 1 lb. weight loss in week 
2 Greater than 2 lb. weight loss in week 
 
17.  Insight        
    0     Acknowledges being depressed and ill 
1 Acknowledges illness but attributes cause to bad food, 
climate, overwork, virus, need for rest, etc. 
2 Denies being ill at all 
 
Total Score:_____________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Patient Name:______________________________________________________________                                              Date:_____________________ 
                                  
                                                  Hamilton Rating Scale for Depression (17-items) 
 
Instructions:  For each item select the “cue” which best characterizes the patient during the past week.   
 
                              
Young Mania Rating Scale (YMRS) 
 
Guide for Scoring Items – The purpose of each item is to rate the severity of that abnormality in the patient.  When several 
keys are given for a particular grade of severity, the presence of only one is required to qualify for that rating. 
 The keys provided are guides.  One can ignore the keys if that is necessary to indicate severity, although this should be 
the exception rather than the rule. 
 Scoring between the points given (whole or half points) is possible and encouraged after experience with the scale is 
acquired.  This is particularly useful when severity of a particular item in a patient does not follow the progression indicated 
by the keys. 
 
1. Elevated Mood 
0 Absent 
1 Mildly or possibly increased on questioning 
2 Definite subjective elevation; optimistic, self-
confident; cheerful; appropriate to content 
3 Elevated, inappropriate to content; humorous 
4 Euphoric; inappropriate to content; singing 
 
2. Increased Motor Activity – Energy 
0 Absent 
1 Subjectively increased 
2 Animated; gestures increased 
3 Excessive energy; hyperactive at times; restless 
(can be calmed) 
4 Motor excitement; continuous hyperactivity 
(cannot be calmed) 
 
3. Sexual Interest 
0 Normal; not increased 
1 Mildly or possibly increased 
2 Definitive subjective increase on questioning 
3 Spontaneous sexual content; elaborates on sexual 
matters; hypersexual by self-report 
4 Overt sexual acts (towards patients, staff, or 
interviewer) 
 
4. Sleep 
0 Reports no decrease in sleep 
1 Sleeping less than normal amount by up to one 
hour 
2 Sleeping less than normal by more than one hour 
3 Reports decreased need for sleep 
4 Denies need for sleep 
 
5. Irritability 
0 Absent 
2 Subjectively increased 
4 Irritable at times during interview; recent 
episodes of anger or annoyance on ward 
6 Frequently irritable during interview; short, curt 
throughout 
8 Hostile, uncooperative; interview impossible 
 
6. Speech (Rate and Amount) 
0 No increase 
2 Feels talkative 
4 Increased rate or amount at times, verbose at 
times 
6 Push; consistently increased rate and amount; 
difficult to interrupt 
8 Pressured; uninterruptible, continuous speech 
7. Language – Thought Disorder 
0 Absent 
1 Circumstantial; mild distractibility; quick 
thoughts 
2 Distractible; loses goal of thought; changes 
topics frequently; racing thoughts 
3 Flight of ideas; tangentiality; difficult to follow; 
rhyming; echolalia 
4 Incoherent; communication impossible 
 
8. Content 
0 Normal 
2 Questionable plans, new interests 
4 Special project(s); hyperreligious 
6 Grandiose or paranoid ideas; ideas of reference 
8 Delusions; hallucinations 
 
9. Disruptive – Aggressive Behavior 
0 Absent; cooperative 
2 Sarcastic; loud at times; guarded 
4 Demanding; threats on ward 
6 Threatens interviewer; shouting; interview 
difficult 
8 Assaultive; destructive; interview impossible 
 
10. Appearance 
0 Appropriate dress and grooming 
1 Minimally unkempt 
2 Poorly groomed; moderately disheveled; 
overdressed 
3 Disheveled; partly clothed; garish makeup 
4 Completely unkempt; decorated; bizarre garb 
 
11. Insight 
0 Present; admits illness; agrees with need for 
treatment 
1 Possibly ill 
2 Admits behavior change, but denies illness 
3 Admits possible change in behavior, but denies 
illness 
4 Denies any behavior changes 
 
 
 
Name:         
 
Rater:         
 
Date:      
 
Score:      
S.no Age Sex No.of Years of educationEducation Marital Status Substance Use Occupation Income primary care giver care giver education Family History
1 23 Male Graduate 15 Unmarried smoking Skilled Middle Sibling Graduate Absent
2 36 Male Secondary 8 Married both Unskilled Middle Spouse Higher Secondary Absent
3 26 Female Graduate 15 Unmarried Absent Skilled Middle Mother Higher Secondary Absent
4 24 Female Graduate 15 Unmarried Absent Skilled Lower Father Primary Present
5 36 Male Secondary 7 Married Alcohol Skilled Middle Spouse Secondary Absent
6 23 Female Graduate 15 Married Absent Not Employed Middle Father Secondary Absent
7 46 Male Secondary 6 Married Absent Unskilled Lower Children Higher Secondary Absent
8 37 Male Higher Secondary 11 Married Absent Skilled Lower Spouse Primary Absent
9 51 Male Higher Secondary 8 Married smoking Unskilled Lower Children Graduate Absent
10 25 Male Graduate 15 Unmarried smoking Skilled Upper Father Primary Present
11 26 Male Graduate 15 Unmarried others Skilled Middle Mother Primary Absent
12 52 Female Higher Secondary 12 Married Absent Skilled Middle Children Higher Secondary Absent
13 23 Male Higher Secondary 11 Unmarried Absent Not Employed Middle Mother Graduate Absent
14 23 Female Graduate 15 Divorced Absent Not Employed Middle Father Primary Absent
15 43 Female Graduate 15 Divorced Absent Home Maker Upper Father Higher Secondary Absent
16 20 Male Secondary 8 Unmarried Absent Unskilled Middle Father Primary Absent
17 33 Female Graduate 15 Unmarried Absent Skilled Middle Mother Higher Secondary Present
18 25 Male Graduate 15 Unmarried Absent Skilled Upper Sibling Secondary Absent
19 34 Female Post Graduate 18 Married Absent Not Employed Middle Spouse Post Graduate Absent
20 28 Female Graduate 15 Married Absent Skilled Middle Mother Primary Absent
21 35 Female Graduate 15 Married Absent Home Maker Lower Spouse Secondary Absent
22 60 Male Graduate 17 Married Absent Skilled Upper Children Graduate Present
23 40 Male Secondary 8 Married both Unskilled Lower Spouse Higher Secondary Absent
24 18 Male Higher Secondary 12 Unmarried Absent Student Middle Mother Higher Secondary Absent
25 42 Male Graduate 15 Married both Skilled Upper Spouse Graduate Absent
26 23 Female Secondary 7 Married Absent Home Maker Lower Mother Primary Present
27 18 Male Graduate 15 Unmarried Absent Unskilled Middle Mother Secondary Absent
28 23 Male Secondary 7 Unmarried Absent Skilled Middle Father Primary Absent
29 36 Male Primary 4 Unmarried Absent Unskilled Lower Sibling Primary Absent
30 55 Female Primary 3 Married Absent Not Employed Lower Children Graduate Present
31 59 Female Primary 5 Married Absent Home Maker Middle Spouse Higher Secondary Absent
32 27 Male Secondary 9 Married others Skilled Middle Spouse Higher Secondary Absent
33 25 Male Higher Secondary 12 Unmarried Alcohol Skilled Upper Father Higher Secondary Present
34 52 Female Higher Secondary 12 Married Absent Home Maker Middle Children Graduate Absent
35 50 Female Secondary 6 Married Absent Unskilled Middle Spouse Higher Secondary Absent
36 42 Male Secondary 7 Married both Skilled Middle Spouse Primary Absent
37 25 Female Post Graduate 16 Unmarried Absent Student Middle Father Secondary Present
38 51 Female Primary 2 Married Absent Home Maker Middle Children Secondary Absent
39 44 Male Secondary 8 Married others Skilled Middle Father Primary Absent
Age of onset Duration of illness No.Of Hospitalization Duration on Lithium No.Of Episodes Dose at discharge Lithium level Current episode psychotic symtoms P - BL R - BL
23 12 2 3 10 1000 0.56 Depression Absent 15 13
30 72 3 3 36 1200 0.78 Mania Absent 11 9
20 72 3 3 36 1000 0.96 Mania Absent 12 12
24 12 2 2 10 1000 1.02 Mania Absent 12
32 54 3 3 48 1200 1.05 Mania Absent 13 8
20 36 2 2 9 1100 0.83 Mania Absent 14 5
40 72 3 4 6 900 0.78 Mania Absent 16
35 24 2 2 7 1000 0.78 Mania Present 8 5
45 72 2 2 7 1000 0.91 Mania Absent 13
22 36 3 4 12 1000 0.79 Mania Absent 16
22 48 3 3 5 1200 0.65 Mania Present 11 8
30 132 5 5 36 1200 1 Mania Absent 6 17
21 36 2 3 6 1000 0.78 Mania Absent 10
21 36 2 2 4 1400 0.75 Mania Present 14 12
30 156 6 6 12 1200 0.85 Mania Absent 15 13
20 3 1 2 1 1200 0.9 Mania Present 9 11
23 120 3 3 60 1000 0.78 Mania Absent 9 20
25 2 1 1 1 1200 0.8 Mania Absent 5 5
29 60 3 3 36 1400 1.1 Mania Absent 10
24 48 3 3 12 1500 1.1 Mania Absent 16 8
23 144 5 6 60 1800 0.83 Mania Absent 13 7
40 240 4 4 60 1200 0.79 Mania Absent 6
35 60 3 3 48 1200 1.07 Mania Absent 10 7
14 48 3 3 24 1200 0.97 Mania Present 14 12
32 120 3 3 24 1200 0.85 Mania Absent 8 9
20 36 2 2 6 800 0.91 Mania Absent 11
17 12 2 2 4 1000 1.2 Depression Present 3 3
23 6 1 2 2 1200 0.9 Mania Present 6 2
31 60 4 4 48 2000 1 Depression Present 4 8
53 24 2 1 1 1000 Mania Present 1 3
20 468 2 5 48 1200 Mania Absent 10 12
26 12 1 1 48 1200 Mania Present 7 1
15 120 4 5 48 1200 0.9 Mania Absent 13 5
28 288 7 8 12 800 Mania Present 6
48 12 1 2 1 1200 Mania Present 9 7
25 204 1 2 1 1200 Mania Present 5 0
22 36 1 2 12 1200 Mania Absent 11
45 60 3 3 1 1000 Mania Present 6
27 180 1 2 1 800 Mania Absent 1 1
